45 results
Page 2 of 3
8-K
EX-99.1
avmgu 52y8n
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
8-K
EX-10.3
y406dejhuelfdkd
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
ic41ubnwnzi7
14 Jan 22
Prospectus supplement
5:18pm
424B5
cayue9w2by7xl
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
s5pin
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
xmbzlwg0h7p7pe oykid
22 Nov 21
Definitive proxy
4:37pm
424B5
qqg vk7e9g2wx
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
vt9q6hv2q1r ghrl4e
14 May 21
Quarterly report
4:31pm
10-K
EX-10.1
78ryuseqi uemqy
31 Mar 21
Annual report
4:30pm
10-K
gnav1qo3og2h9b3pci7
31 Mar 21
Annual report
4:30pm
S-3
g20 0z9tjq
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
bgurgd5fptbzqdq8xbu
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
m6z 1ypm9m46t23li
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-10.1
tc6k dpm6xge3mhfdlpp
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
s009yfw295ieb9zp5au
2 Nov 20
Prospectus supplement
12:00am